Demand for bariatric surgery to treat severe and resistant obesity far outstrips supply. We
aimed to comprehensively synthesise health economic evidence regarding bariatric surgery …

This systematic review aimed to comprehensively synthesize cost-effectiveness evidences
of bariatric surgery by pooling incremental net monetary benefits (INB). Twenty-eight full …

Abstract Introduction The Asia-Pacific Metabolic and Bariatric Surgery Society (APMBSS)
held its congress in Tokyo at the end of March, 2018, and representatives from Asia-Pacific …

Background: Obesity is a risk factor for diabetes and several cardiovascular diseases. This
study was to investigate the trends in the prevalence, awareness, and management status of …

Background In the current healthcare environment, bariatric surgery centers need to be cost-
effective while maintaining quality. Objective The aim of this study was to evaluate national …

Purpose Sacubitril/valsartan, the first-in-class angiotensin receptor neprilysin inhibitor
(ARNI), is a possible treatment option for chronic heart failure patients with reduced ejection …

Abstract Background On November 25, 2021, the IFSO-Asia–Pacific Chapter (IFSO-APC)
Virtual Meeting 2021 was held online, and the representatives from the Asia–Pacific region …

Bariatric surgery among patients with morbid obesity is very effective for providing long-term
weight loss and remission of obesity-related co-morbidities. However, it is very expensive …

Obesity, defined as BMI≥ 30 kg/m 2, affects over 30% of the United States adult population
and has been declared an epidemic by the Centers for Disease Control. Bariatric surgery is …

Background Health economic evaluations inform healthcare resource allocation decisions
for treatment options for obesity including bariatric/metabolic surgery. As an important …